Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Jan-Mar;3(1):e23284.
doi: 10.4161/biom.23284. Epub 2013 Jan 1.

Delivery of EPC embedded in HA-hydrogels for treatment of acute kidney injury

Affiliations
Review

Delivery of EPC embedded in HA-hydrogels for treatment of acute kidney injury

Brian B Ratliff et al. Biomatter. 2013 Jan-Mar.

Abstract

Adoptive transfer of stem cells has shown potential as an effective treatment for acute kidney injury (AKI). The current strategy for adoptive transfer of stem cells is by intravenous injection. However, this conventional method of stem cell delivery is riddled with problems causing reduced efficacy of the therapeutic potential of delivered stem cells. This review summarizes the recent advancements in an alternative method of stem cell delivery for treatment of AKI, embedding stem cells in hyaluronic acid (HA-) based hydrogels followed by their implantation. Furthermore, one stem cell type in particular, endothelial progenitor cells (EPC), have shown remarkable therapeutic benefits for treatment of AKI when delivered by HA-hydrogels. The review also summarizes the delivery of EPC by HA-hydrogels in the setting of AKI.

Keywords: Adriamycin-induced kidney injury; acute kidney injury; endothelial progenitor cells; endotoxemia; hyaluronic acid based hydrogels; sepsis; stem cell therapy.

PubMed Disclaimer

Figures

None
Figure 1. Schematic of the implantation of HA-hydrogels and subsequent release and mobilization of embedded EPC for treatment of AKI in a mouse model. 1) HA-hydrogels with embedded EPC are implanted either superficially into ears or subcapsularly into kidneys. 2) Induction of AKI (cyto-/endotoxins). 3a) Kidney implants are digested by endogenous release of hyaluronidase from the kidneys during AKI and embedded EPC are mobilized into the kidney, or 3b) ear implants are digested by direct injection of hydrogel-digesting enzymes and embedded EPC are mobilized into the circulation. 4) Released EPC generate therapeutic effects (see Tables 1 and 2).
None
Figure 2.Schematic representation (left) and corresponding images (right) (40x magnification) of EPC treated with 10 ug/ml LPS for 24 h. During LPS treatment, EPC were plated on culture plates (A) (without HA-hydrogel embedding), embedded in HA-hydrogels (B), or embedded in HA-hydrogels along with MSC (C). Embedding EPC in HA-hydrogels improved EPC viability and resistance to endotoxins, an effect that was considerably enhanced when EPC were co-embedded with MSC. To determine cell viability, cells were subject to a LIVE/DEAD assay in which live cells were stained green with calcein and dead cells were stained red with ethidium homodimer.

Similar articles

Cited by

References

    1. Baddour JA, Sousounis K, Tsonis PA. Organ repair and regeneration: an overview. Birth Defects Res C Embryo Today. 2012;96:1–29. doi: 10.1002/bdrc.21006. - DOI - PubMed
    1. Ghaly T, Rabadi MM, Weber M, Rabadi SM, Bank M, Grom JM, et al. Hydrogel-embedded endothelial progenitor cells evade LPS and mitigate endotoxemia. Am J Physiol Renal Physiol. 2011;301:F802–12. doi: 10.1152/ajprenal.00124.2011. - DOI - PMC - PubMed
    1. Kale S, Karihaloo A, Clark PR, Kashgarian M, Krause DS, Cantley LG. Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest. 2003;112:42–9. - PMC - PubMed
    1. Park HC, Yasuda K, Ratliff B, Stoessel A, Sharkovska Y, Yamamoto I, et al. Postobstructive regeneration of kidney is derailed when surge in renal stem cells during course of unilateral ureteral obstruction is halted. Am J Physiol Renal Physiol. 2010;298:F357–64. doi: 10.1152/ajprenal.00542.2009. - DOI - PMC - PubMed
    1. Patschan D, Plotkin M, Goligorsky MS. Therapeutic use of stem and endothelial progenitor cells in acute renal injury: ça ira. Curr Opin Pharmacol. 2006;6:176–83. doi: 10.1016/j.coph.2005.10.013. - DOI - PubMed

Publication types

MeSH terms